Design, synthesis, and anti-tumor evaluation of novel symmetrical bis-benzimidazoles

European Journal of Medicinal Chemistry
2009.0

Abstract

A novel symmetrical bis-benzimidazole was designed as DNA minor groove binder. Molecular modeling study showed that it could dock into the minor groove of DNA. Several derivatives were synthesized and confirmed by IR, MS, and (1)H NMR. All these novel compounds were screened for cytotoxic activity on SKOV-3, HeLa, and BGC-823 cell lines in vitro. Some compounds showed IC(50)s in the single-digit micromolar range for cytotoxicity in several tumor cell lines.

Knowledge Graph

Similar Paper

Design, synthesis, and anti-tumor evaluation of novel symmetrical bis-benzimidazoles
European Journal of Medicinal Chemistry 2009.0
A New Class of Symmetric Bisbenzimidazole-Based DNA Minor Groove-Binding Agents Showing Antitumor Activity
Journal of Medicinal Chemistry 2001.0
Newly synthesized bis-benzimidazole derivatives exerting anti-tumor activity through induction of apoptosis and autophagy
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-Aryl-substituted 2-bis-1H-benzimidazoles
European Journal of Medicinal Chemistry 2011.0
Novel benzimidazole–pyrimidine conjugates as potent antitumor agents
European Journal of Medicinal Chemistry 2010.0
New anticancer active and selective phenylene-bisbenzothiazoles: Synthesis, antiproliferative evaluation and DNA binding
European Journal of Medicinal Chemistry 2013.0
Synthesis and DNA Interactions of Benzimidazole Dications Which Have Activity against Opportunistic Infections
Journal of Medicinal Chemistry 1996.0
Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties
European Journal of Medicinal Chemistry 2017.0
Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives
European Journal of Medicinal Chemistry 2011.0
Synthesis and cytotoxic activity of novel hexahydropyrrolo[2,3- b ]indole imidazolium salts
Bioorganic & Medicinal Chemistry Letters 2016.0